Aminotransferases (Transaminases)

What are Aminotransferases (transaminases)?

Aminotransferases (often called transaminases) are enzymes that transfer amino groups between amino acids and keto acids. Clinically, the term usually refers to alanine aminotransferase (ALT) and aspartate aminotransferase (AST) measured in blood. These enzymes are present in multiple tissues, including liver and muscle, and they enter the circulation when cells are injured. Transaminitis refers to an elevation in AST and/or ALT on laboratory testing and is interpreted as a marker of tissue injury rather than a diagnosis. ALT is more concentrated in hepatocyte cytosol, while AST has a broader distribution, which helps interpret patterns of elevation.

What causes elevated Aminotransferases (transaminases)?

Transaminases rise when cellular injury disrupts membranes and releases intracellular enzymes into plasma. Hepatic causes include inflammatory, toxic, ischemic, and immune-mediated injury (for example, viral hepatitis, alcohol-associated liver disease, metabolic fatty liver disease, ischemic hepatitis from hypotension, drug-induced liver injury, and autoimmune hepatitis). Nonhepatic sources can also contribute, particularly skeletal muscle injury (check creatine kinase), hemolysis-related interference, or macroenzyme complexes (rare), so interpretation requires correlation with clinical context and other laboratory markers. Chronic liver disease often produces persistent mild-to-moderate elevations, whereas acute toxic or ischemic injury can produce abrupt, marked increases.

What are the signs and symptoms of elevated Aminotransferases (transaminases)?

Elevated transaminases do not produce symptoms by themselves. Symptoms, when present, reflect the underlying condition driving hepatocellular injury or cholestasis. Individuals with acute hepatic inflammation may develop right upper quadrant discomfort, malaise, anorexia, or jaundice. Coagulopathy or encephalopathy suggests acute liver failure and warrants urgent evaluation. In chronic disease, symptoms may be nonspecific (such as fatigue or pruritus) and are better interpreted in combination with the pattern of laboratory abnormalities and risk factors.

How is the cause of elevated Aminotransferases (transaminases) diagnosed?

Evaluation begins with AST and ALT as part of a liver biochemical panel and then focuses on identifying the source and pattern of injury. Interpret results by pattern (hepatocellular vs cholestatic using alkaline phosphatase and bilirubin) and assess severity, including synthetic function (INR and albumin) when elevations are significant or symptoms suggest acute liver injury. Reference ranges vary by laboratory, so results should be interpreted against local cutoffs and the degree of elevation. Follow-up testing commonly includes viral hepatitis serologies, targeted studies for metabolic liver disease (such as iron studies and ceruloplasmin when indicated), and autoimmune markers when clinical features support that possibility. Abdominal ultrasound helps assess biliary obstruction and structural hepatic disease, and elastography can support fibrosis assessment in suspected chronic disease. A careful medication and toxin history is essential, because drug-induced injury and alcohol-associated hepatitis can produce characteristic patterns and may require immediate exposure cessation.

How are elevated Aminotransferases (transaminases) treated?

Management targets the underlying cause rather than the enzyme elevation itself. This may include antiviral therapy for viral hepatitis, immunosuppression for autoimmune hepatitis, and metabolic risk reduction (weight loss and glycemic control) for steatohepatitis. For suspected drug-induced liver injury, discontinuing the offending agent is central, with supportive care as needed; N-acetylcysteine is used for acetaminophen toxicity. Alcohol cessation and nutritional support reduce progression risk in alcohol-associated liver disease. Serial monitoring of transaminases helps document response and detect progression toward fibrosis or cirrhosis, with hepatology referral based on severity, persistence, or accompanying synthetic dysfunction.

What are the most important facts to know about Aminotransferases (transaminases)?

• Aminotransferase (transaminase) elevations indicate tissue injury and require a clinical context to determine the source and cause.
• Transaminitis describes a laboratory finding, not a standalone diagnosis, and elevations can be hepatic or nonhepatic (especially muscle-related).
• ALT is more liver-concentrated, while AST is more widely distributed, so patterns and ratios can refine differential considerations.
• Workup typically combines repeat testing, risk-focused laboratory evaluation, and imaging, escalating to specialist assessment when abnormalities persist or severity is high.
• Treatment addresses the underlying insult (viral, immune, toxic, ischemic, or metabolic) and uses trend monitoring to guide follow-up and referral.